Orchard Software Announces New Electronic Support for Antimicrobial Stewardship
Orchard Software Announces New Electronic Support for Antimicrobial Stewardship
CARMEL, Ind., April 4, 2024 /PRNewswire/ -- Today, Orchard Software announced the availability of Antimicrobial Use and Resistance (AUR) reporting to the National Healthcare Safety Network (NHSN), which supports regulatory requirements and antimicrobial stewardship endeavors.
印第安納州卡梅爾，2024年4月4日 /PRNewswire/ — 今天，Orchard Software宣佈向國家醫療安全網絡（NHSN）提供抗微生物藥物使用和耐藥性（AUR）報告，該報告支持監管要求和抗微生物藥物管理工作。
AUR reporting and data analysis promotes antimicrobial stewardship and impedes the transmission of resistant pathogens. In 2024, the NHSN began requiring hospitals to report AUR data as part of the Public Health and Clinical Data Exchange objective of the Promoting Interoperability Program. Orchard's solutions support this integration and provide a mechanism to automate the submission of designated antibiotic interpretations and susceptibility results to NHSN via HL7 interface.
AUR 報告和數據分析促進抗微生物藥物管理，阻礙耐藥性病原體的傳播。2024年，作爲促進互操作性計劃公共衛生和臨床數據交換目標的一部分，NHSN開始要求醫院報告AUR數據。Orchard的解決方案支持這種整合，並提供了一種通過HL7接口自動向NHSN提交指定的抗生素解釋和敏感性結果的機制。
"At Orchard, we are continually looking for ways to support our customers and the valuable work they do. Adding AUR reporting is one more way that we can provide superior support to our customers," said Billie Whitehurst, CEO of Orchard Software. "We understand the importance of antimicrobial stewardship and that improving the use of antimicrobials to prevent antibiotic resistance is one of the CDC's core objectives. We are pleased to contribute to tracking of antimicrobial use as a tool for improvement within the laboratory and public health industries."
“在 Orchard，我們一直在尋找方法來支持我們的客戶和他們所做的寶貴工作。添加AUR報告是我們爲客戶提供卓越支持的另一種方式。” Orchard Software首席執行官比利·懷特赫斯特說。“我們了解抗微生物藥物管理的重要性，改善抗微生物藥物的使用以預防抗生素耐藥性是疾病預防控制中心的核心目標之一。我們很高興爲跟蹤抗微生物藥物的使用情況做出貢獻，以此作爲改善實驗室和公共衛生行業的工具。”
AUR is used to track antimicrobial resistant infections and evaluate antibiotic use trends over time. Providing antimicrobial usage reports to providers can improve appropriate antimicrobial use. Orchard's solutions support this endeavor and are easily configurable to include antibiotic interpretations that enable required reporting to NHSN.
AUR 用於跟蹤抗微生物藥物耐藥性感染和評估一段時間內的抗生素使用趨勢。向提供者提供抗微生物藥物使用報告可以改善抗微生物藥物的適當使用。Orchard 的解決方案支持這項工作，並且易於配置以包括抗生素解釋，從而能夠按要求向 NHSN 報告。
About Orchard Software Corporation
Orchard Software Corporation is a leader in the laboratory information system industry and offers a variety of solutions. Orchard serves more than 2,000 laboratories across the country, helping them improve efficiency, reduce errors, and enhance integration. Orchard's cloud-based solutions are installed in physician groups and clinics, hospitals, independent reference labs, student health centers, veterinary labs, public health organizations, universities, and retail facilities. For more information regarding Orchard Software Corporation, visit .
Orchard 軟件公司簡介
Orchard Software Corporation是實驗室信息系統行業的領導者，提供各種解決方案。Orchard 爲全國各地的 2,000 多個實驗室提供服務，幫助他們提高效率、減少錯誤和加強整合。Orchard 基於雲的解決方案安裝在醫生團體和診所、醫院、獨立參考實驗室、學生健康中心、獸醫實驗室、公共衛生組織、大學和零售設施中。有關 Orchard 軟件公司的更多信息，請訪問。
Media Contact:
Steve Hurwitz, Vice President of Marketing
(800) 856-1948 | [email protected]
媒體聯繫人：
Steve Hurwitz，市場營銷副總裁
(800) 856-1948 | [電子郵件保護]
SOURCE Orchard Software Corporation
來源 Orchard 軟件公司
譯文內容由第三人軟體翻譯。